BiotechTube
Home/Pipeline/TSY-110

TSY-110

HER2-positive cancers (ADC biosimilar)

DevelopmentActive

Key Facts

Indication
HER2-positive cancers (ADC biosimilar)
Phase
Development
Status
Active
Company
Formosa Pharmaceuticals

About Formosa Pharmaceuticals

A clinical-stage biotech company developing ophthalmology and oncology therapies using its proprietary APNT® nanoparticle platform and ADC technology.

View full company profile

Therapeutic Areas

OphthalmologyOncologyAnti-infectives

Other HER2-positive cancers (ADC biosimilar) Drugs

DrugCompanyPhase
TSY-120Formosa PharmaceuticalsDevelopment